Digitally Join the RNAi-Based Therapeutics Community

We are excited to announce that the RNAi-Based Therapeutics Summit has gone virtual!

As the first multi-disciplinary discussion for large pharma, biotech and academic leaders specifically dedicated to the RNAi therapeutics, the industry will be coming together on Wednesday, July 22 to successfully optimize cell-specific strategies, overcome pharmacology and delivery challenges to accelerate translation and clinical development of RNAi therapeutics in the liver, CNS and beyond.

Check out the official event guide for full speaker and session details.

Join this virtual summit to meet those pioneering the field and to hear from 19+ world-class experts that are sharing their latest perspectives:

• Dong-ki Lee, Founder & Chief Executive Officer, OliX Pharmaceuticals
• Elena Feinstein, Chief Scientific Officer, Quark Pharmaceuticals
• Karyn O’Neil, Chief Scientific Officer, Aro Biotherapeutics
• Brooke Rock, Director, Amgen
• Sharmistha Ghosh, Associate Director, Arrowhead Pharmaceuticals
• Baisong Mei, Senior Global Project Head, Sanofi
• David Corey, Professor, UT Southwestern

Download the updated program to see the full list.

With several clinical candidates emerging and momentum building in the field, join the RNAi-Based Therapeutics Summit – your comprehensive, industry-focused virtual meeting dedicated to bringing together senior biopharmaceutical leaders from discovery, translation, and clinical development functions to advance pioneering RNAi platforms that improve patient outcomes. Secure your ticket now.

Looking forward to seeing you at our virtual meeting!